Metoprolol injection
Pro Research Analysisby 
Searched over 200M research papers for "metoprolol injection"
Metoprolol Injection: Efficacy, Safety, and Clinical Applications
Introduction to Metoprolol Injection
Metoprolol, a beta-blocker, is widely used in various clinical settings, particularly for cardiovascular conditions. This article synthesizes recent research on the efficacy, safety, and clinical applications of metoprolol injection.
Efficacy in Myocardial Infarction
Reducing Infarct Size and Mortality
Early administration of intravenous (IV) metoprolol during myocardial infarction (MI) has shown significant benefits. In a study involving pigs, metoprolol reduced infarct size (IS) progression and overall mortality. The treatment also decreased the incidence of primary ventricular fibrillation during infarct induction, highlighting its potential in managing STEMI patients, especially those requiring long transport times before primary angioplasty .
Long-term Benefits on Left Ventricular Function
The METOCARD-CNIC trial demonstrated that early IV metoprolol before reperfusion in STEMI patients resulted in higher long-term left ventricular ejection fraction (LVEF) and reduced severe LV systolic dysfunction. Additionally, it lowered the incidence of heart failure admissions and the need for implantable cardioverter-defibrillators (ICDs) .
Impact on Congestive Heart Failure
In patients with suspected acute MI and signs of congestive heart failure (CHF), early metoprolol treatment significantly reduced mortality rates at both 3 months and 1 year. This suggests that metoprolol can markedly improve prognosis in this patient subgroup .
Safety and Tolerability
Hemodynamic Stability
Metoprolol has been shown to be hemodynamically stable in patients with acute MI. Studies indicate that it effectively reduces heart rate, systolic blood pressure, and cardiac index without causing significant adverse effects. Even in patients with low heart rates, metoprolol was well-tolerated and did not lead to serious hemodynamic instability Held1985Held1986.
Retinal Safety
In a study assessing the safety of intravitreal metoprolol tartrate in rabbits, no clinical toxicity was observed. Electroretinography and histological evaluations confirmed that metoprolol did not cause short-term retinal toxicity, suggesting its potential safety for ocular applications .
Clinical Applications Beyond Cardiovascular Use
Pain Management During Propofol Injection
Metoprolol has also been investigated for its efficacy in reducing pain associated with propofol injection. A study comparing metoprolol with lidocaine found that both were equally effective in reducing the incidence and severity of pain, offering an alternative for pain management in clinical settings .
Anti-inflammatory Effects
In a rat model of coronary microembolization, metoprolol administration reduced levels of inflammatory cytokines such as TNF-α and IL-1β, while increasing IL-10 levels. This anti-inflammatory effect was associated with improved left ventricular function, indicating metoprolol's potential in managing myocardial inflammation and contractile dysfunction .
Stability of Metoprolol Injection
Metoprolol tartrate injection has been found to be stable for at least 30 hours at room temperature, whether undiluted or diluted in 0.9% sodium chloride or 5% dextrose injection. This stability ensures its efficacy and safety during clinical use .
Conclusion
Metoprolol injection offers significant benefits in managing myocardial infarction, reducing infarct size, and improving long-term cardiac function. It is hemodynamically stable and well-tolerated, even in patients with low heart rates. Additionally, its potential applications in pain management and anti-inflammatory effects broaden its clinical utility. The stability of metoprolol injection further supports its use in various medical settings.
Sources and full results
Most relevant research papers on this topic
Metoprolol blunts the time-dependent progression of infarct size
Metoprolol administration early during ischemia reduces infarct size progression and the incidence of primary ventricular fibrillation, making it ideal for treating STEMI patients with early infarctions.
Assessment of the safety of intravitreal injection of metoprolol tartrate in rabbits
Intravitreal metoprolol at 50 and 100 g dosages does not cause short-term retinal toxicity in rabbits.
Stability of metoprolol tartrate injection 1 mg/mL undiluted and 0.5 mg/mL in 0.9% sodium chloride injection and 5% dextrose injection.
Metoprolol tartrate injections, undiluted and diluted, remain stable at room temperature for at least 30 hours without significant changes in pH, color, or microbial growth.
DOI